“…2 Experimental evidence, first collected in Drosophila melanogaster 3 and later extended to mammalian cells, 4 implicates Scrib as a general regulator of directional cell motility, largely via the assembly of multiprotein complexes and the activation of small GTPase signaling at the leading edge of migrating cells. 5,6 Accordingly, loss-of-function Scrib mutants 7 or depletion of Scrib 4 has disrupted apical-basal polarity 8 and has cooperated with oncogenic signals 9 to enhance tumor cell migration, invasion, and survival. 10 Although these data have prompted a model that Scrib may function in an evolutionary-conserved pathway of tumor suppression, 1,3 its role in human cancer, in vivo, has remained vehemently debated.…”